Welcome to our dedicated page for Tactile Systems SEC filings (Ticker: TCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Tactile Systems Technology, Inc. (Tactile Medical) SEC filings page for ticker TCMD provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed medical technology company incorporated in Delaware, Tactile Medical files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K under Commission File Number 001-37799.
Through these filings, investors can review detailed information on Tactile Medical’s business, including its focus on at-home therapies for lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. Periodic reports describe revenue from sales and rentals of the lymphedema product line and sales of the airway clearance product line, along with discussions of gross margin, operating expenses, net income or loss and non-GAAP measures such as Adjusted EBITDA as defined by the company.
Current reports on Form 8-K document material events, such as the release of quarterly financial results and the authorization of share repurchase programs for the company’s common stock. These filings may include information on the size and duration of repurchase authorizations and the company’s intention to fund them from cash and future cash flows.
On Stock Titan, TCMD filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries highlight key points from lengthy documents, helping users quickly understand topics such as segment performance, capital allocation decisions and risk factor discussions without reading every page. Users can also review insider-related filings, including Forms 3, 4 and 5, to track equity transactions by directors and officers, and proxy statements on Schedule 14A for information on governance and executive compensation.
Whether you are analyzing Tactile Medical’s financial history, monitoring new 8-K disclosures or looking for details on its at-home therapy business, this page centralizes the company’s official SEC filings with concise AI-generated insights.
The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting zero beneficial ownership of Tactile Systems Technology Inc common stock. The filing states that, following an internal realignment on January 12, 2026 and in reliance on SEC Release No. 34-39538, certain Vanguard subsidiaries will report holdings separately and The Vanguard Group no longer is deemed to beneficially own securities held by those subsidiaries. The filing lists 0 shares and 0% beneficial ownership and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Tactile Systems Technology, Inc. is asking stockholders to vote at its May 6, 2026 annual meeting on four main items: electing nine directors, ratifying Grant Thornton LLP as auditor, approving 2025 executive pay on an advisory basis, and amending its charter so directors can be removed with or without cause by a majority vote, consistent with Delaware law.
The board notes that 8 of 9 nominees are independent and that the chair and CEO roles are separated. Executive pay is framed as pay-for-performance: in 2025 the company generated $329.5 million in revenue and $44.8 million in Adjusted EBITDA, resulting in management incentive plan payouts at 115% of target and strong PSU vesting outcomes tied to revenue growth and margin.
Pearson Andrea reported acquisition or exercise transactions in this Form 4 filing.
Tactile Systems Technology Inc. director Andrea Pearson received an equity award of 852 shares of Common Stock. These shares are in the form of restricted stock units granted at no cash cost and will vest in full on the date of the company's 2026 annual meeting of stockholders. Following this grant, Pearson holds 852 shares directly, indicating this filing reflects a routine compensation-related award rather than an open-market purchase or sale.
Tactile Systems Technology Inc. director Andrea Pearson filed an initial statement of beneficial ownership as required for insiders. The Form 3 data identifies her role as a director and shows no reported insider transactions or derivative holdings associated with this filing.
Tactile Systems Technology, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held on May 6, 2026, with a record date of March 12, 2026.
The meeting asks holders to elect nine directors, ratify Grant Thornton LLP as auditor for the year ending December 31, 2026, approve an advisory "say-on-pay" for 2025 executive compensation, and approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to permit director removal in a manner consistent with Delaware law. Proxy voting methods and meeting logistics are provided.
Tactile Systems Technology, Inc. appointed Andrea A. Pearson to its board of directors, effective March 9, 2026, and set the board size at nine members. She will serve on the Compliance and Reimbursement Committee and the Nominating and Corporate Governance Committee.
For her board service, Ms. Pearson will receive restricted stock units valued at a pro rata portion of $155,000, granted March 9, 2026, vesting on the date of the Company’s 2026 annual stockholders’ meeting if she remains a director. She will also receive annual cash retainers of $50,000 for board service and $5,000 each for her roles on the two committees, all prorated for her first year.
Tactile Systems Technology Chief Executive Officer Sheri Louise Dodd reported an open-market sale of 10,993 shares of common stock on February 24, 2026 at a weighted average price of $28.9406 per share. According to the disclosure, these shares were sold to cover taxes associated with the settlement of stock units. After this transaction, Dodd directly owns 243,885 shares of Tactile Systems Technology common stock. The sale was executed in multiple trades with prices ranging from $28.50 to $29.45 per share.
Tactile Systems Technology Inc. chief financial officer Elaine M. Birkemeyer reported an open-market sale of 7,701 shares of common stock on February 24, 2026. The shares were sold to cover taxes associated with the settlement of stock units.
The filing states a weighted average sale price of $28.9417 per share, with individual trades executed between $28.50 and $29.45 per share. After this transaction, Birkemeyer directly holds 134,819 shares of Tactile Systems common stock.
Tactile Systems Technology senior vice president Kristie Burns sold 6,246 shares of common stock in an open-market transaction. The shares were sold at a weighted average price of $28.9408 per share on February 24, 2026 to cover taxes associated with the settlement of stock units. After this sale, Burns directly owned 82,581 shares of Tactile Systems Technology common stock.